{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:06:04Z","timestamp":1761509164845,"version":"build-2065373602"},"reference-count":15,"publisher":"CSIRO Publishing","issue":"3","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":3143,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,5]]},"abstract":"<jats:p>Visceral leishmaniasis and HIV co-infection presents diagnostic, monitoring and treatment challenges. This is a report of a co-infected patient who developed multiple complications and treatment side-effects, including renal and liver failure, pancytopenia with recurrent sepsis, along with anal cancer, depression and poor quality-of-life spanning over two decades. Urgent research specific to this cohort is needed.<\/jats:p>","DOI":"10.1071\/sh16036","type":"journal-article","created":{"date-parts":[[2017,1,8]],"date-time":"2017-01-08T16:21:09Z","timestamp":1483892469000},"page":"286-288","source":"Crossref","is-referenced-by-count":2,"title":["Managing two decades of visceral leishmaniasis and HIV co-infection: a case report that illustrates the urgent research needs in the field"],"prefix":"10.1071","volume":"14","author":[{"given":"Melissa L.","family":"Kelly","sequence":"first","affiliation":[{"name":"AHIV, Immunology & Infectious Diseases Service, St Vincent\u2019s Hospital, 390 Victoria Street, Darlinghurst, NSW 2010, Australia."},{"name":"ECorresponding author. Email: Melissa_kelly_@hotmail.com"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angie N.","family":"Pinto","sequence":"additional","affiliation":[{"name":"AHIV, Immunology & Infectious Diseases Service, St Vincent\u2019s Hospital, 390 Victoria Street, Darlinghurst, NSW 2010, Australia."},{"name":"BKirby Institute, University of NSW, High Street, Kensington, NSW 2052, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Suan","sequence":"additional","affiliation":[{"name":"AHIV, Immunology & Infectious Diseases Service, St Vincent\u2019s Hospital, 390 Victoria Street, Darlinghurst, NSW 2010, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Marriott","sequence":"additional","affiliation":[{"name":"AHIV, Immunology & Infectious Diseases Service, St Vincent\u2019s Hospital, 390 Victoria Street, Darlinghurst, NSW 2010, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Cooper","sequence":"additional","affiliation":[{"name":"AHIV, Immunology & Infectious Diseases Service, St Vincent\u2019s Hospital, 390 Victoria Street, Darlinghurst, NSW 2010, Australia."},{"name":"BKirby Institute, University of NSW, High Street, Kensington, NSW 2052, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Pett","sequence":"additional","affiliation":[{"name":"AHIV, Immunology & Infectious Diseases Service, St Vincent\u2019s Hospital, 390 Victoria Street, Darlinghurst, NSW 2010, Australia."},{"name":"BKirby Institute, University of NSW, High Street, Kensington, NSW 2052, Australia."},{"name":"CMRC CTU at UCL, University College London, London, WC2B 6NH, UK."},{"name":"DClinical Research Group, Infection and Population Health, UCL, London, WC1E 6JB, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"2025102615582090900_R1"},{"key":"2025102615582090900_R2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QCO.0b013e32835c2198","article-title":"Clinical aspects of visceral leishmaniasis in HIV infection.","volume":"26","author":"Jarvis","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"2025102615582090900_R3","unstructured":"Word Health Organization. Control of the leishmaniases: report of a meeting of the WHO expert committee on the control of leishmaniases. Geneva: World Health Organization; 2010. Available online at: http:\/\/whqlibdoc.who.int\/trs\/WHO_TRS_949_eng.pdf [verified 8 July 2015]."},{"key":"2025102615582090900_R4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years.","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"2025102615582090900_R5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis.","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2025102615582090900_R6","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1128\/JCM.44.3.1178-1180.2006","article-title":"Post-Kala-Azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient.","volume":"44","author":"Stark","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2025102615582090900_R7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4269\/ajtmh.14-0798","article-title":"Rapid tests and the diagnosis of visceral leishmaniasis and HIV\/AIDS co-infection.","volume":"93","author":"Barbosa","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"2025102615582090900_R8","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1093\/cid\/cir674","article-title":"Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence.","volume":"53","author":"Ritmeijer","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025102615582090900_R9","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1086\/591972","article-title":"New treatment approach in Indian visceral leishmaniasis: single dose liposomal amphotericin B follows by short-course oral miltefosine.","volume":"47","author":"Sundar","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2025102615582090900_R10","unstructured":"Ermias D. Efficacy trial of Ambisome given alone and Ambisome given in combination with Miltefosine for the treatment of VL HIV positive Ethiopian patients. 2016. Available online at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02011958 [verified 27 January 2016]."},{"key":"2025102615582090900_R11","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/cid\/civ530","article-title":"Combination treatment for visceral leishmaniasis patients co-infected with human immunodeficiency virus in India.","volume":"61","author":"Mahajan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025102615582090900_R12","doi-asserted-by":"publisher","first-page":"e0004087","DOI":"10.1371\/journal.pntd.0004087","article-title":"Use of pentamidine as secondary prophylaxis to prevent visceral leishmaniasis relapse in HIV infected patients, the first twelve months of a prospective cohort study.","volume":"9","author":"Diro","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2025102615582090900_R13","doi-asserted-by":"publisher","first-page":"e83247","DOI":"10.1371\/journal.pone.0083247","article-title":"In-vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis.","volume":"8","author":"de Macedo-Silva","year":"2013","journal-title":"PLoS One"},{"key":"2025102615582090900_R14","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1128\/AAC.01498-10","article-title":"Successful treatment of old world cutaneous leishmaniasis caused by Leishmania infantum with posaconazole.","volume":"55","author":"Paniz Mondolfi","year":"2011","journal-title":"Antimicrobial Agent Chemotherapy"},{"key":"2025102615582090900_R15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/QCO.0000000000000194","article-title":"Leishmaniasis: treatment updates and clinical practice guidelines.","volume":"28","author":"Copeland","year":"2015","journal-title":"Curr Opin Infect Dis"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/14\/3\/286\/845187\/sh16036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/14\/3\/286\/845187\/sh16036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:58:29Z","timestamp":1761508709000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/14\/3\/286\/106948\/Managing-two-decades-of-visceral-leishmaniasis-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6,5]]}},"URL":"https:\/\/doi.org\/10.1071\/sh16036","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"type":"print","value":"1448-5028"},{"type":"electronic","value":"1449-8987"}],"subject":[],"published":{"date-parts":[[2017,1,9]]}}}